Dechra Pharmaceuticals trading on track in first quarter
Dechra Pharmaceuticals
3,866.00p
08:01 16/01/24
0.00%
0.00p
Dechra Pharmaceuticals got off to a solid start across the board, the specialist veterinary medicines group said ahead of its annual shareholder meeting on Friday.
FTSE 250
20,900.08
17:14 04/10/24
n/a
n/a
FTSE 350
4,570.17
17:14 04/10/24
n/a
n/a
FTSE All-Share
4,527.24
16:54 04/10/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,108.24
17:14 04/10/24
-1.30%
-291.15
The FTSE 250 company said that performance in the first quarter of its new financial year since June was "in line with management expectations, with continued growth across all of its markets".
Dechra will report on its interim results for the half-year to 31 December at the end of February next year.